SCHEMBL6582750

SCHEMBL6582750

COc1ccc(-c2nc(-c3cccc(C=O)c3)nn2CC2CCC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.46
NR1H3 Q13133 2/20 0.46
AVPR1B P47901 10/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PTGIR P43119 1/20 0.39
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPBWR1 P48145 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582793 0.97 NR1H2 (0.47) NR1H2NR1H3AVPR1BL3MBTL1PTGIR
SCHEMBL6581016 0.96 AVPR1B (0.43) NR1H2NR1H3AVPR1BL3MBTL1PTGIR
SCHEMBL6582832 0.93 L3MBTL1 (0.43) NR1H2NR1H3AVPR1BL3MBTL1PTGIR
SCHEMBL6584155 0.85 NR1H3 (0.51) NR1H2NR1H3AVPR1BRAB9ANPC1
SCHEMBL6580712 0.84 NR1H2 (0.40) NR1H2NR1H3AVPR1BL3MBTL1RAB9A
SCHEMBL6578548 0.83 NR1H3 (0.64) NR1H2NR1H3AVPR1BL3MBTL1RAB9A
SCHEMBL6584100 0.82 NR1H2 (0.48) NR1H2NR1H3AVPR1BL3MBTL1RAB9A
SCHEMBL6584148 0.82 NR1H3 (0.48) NR1H2NR1H3AVPR1BRAB9ANPC1
SCHEMBL6578958 0.82 NR1H3 (0.48) NR1H2NR1H3AVPR1BRAB9ANPC1
SCHEMBL6581065 0.82 NR1H3 (0.48) NR1H2NR1H3AVPR1BRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed